Page 255 - Read Online

Page 4 of 4 Aubert et al. Mini-invasive Surg 2019;3:34 I http://dx.doi.org/10.20517/2574-1225.2019.46

systematic review of the literature. Langenbeck’s Arch Surg 2015;400:945-59.
3. Chen CC, Lai YL, Jiang JK, Chu CH, Huang IP, et al. Transanal total mesorectal excision versus laparoscopic surgery for rectal cancer
receiving neoadjuvant chemoradiation: a matched case-control study. Ann Surg Oncol 2016;23:1169-76.
4. Lelong B, de Chaisemartin C, Meillat H, Cournier S, Boher JM, et al. A multicentre randomised controlled trial to evaluate the efficacy,
morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer
(ETAP-GRECCAR 11 TRIAL): rationale and design. BMC Cancer 2017;17:1-8.
5. Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, et al. COLOR III: a multicentre randomised clinical trial comparing
transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc 2016;30:3210-5.
6. Larsen SG, Pfeffer F, Kørner H, Norwegian Colorectal Cancer Group. Norwegian moratorium on transanal total mesorectal excision. Br
J Surg 2019;106:1120-1.
7. Penna M, Hompes R, Arnold S, Wynn G, Austin R, et al. Incidence and risk factors for anastomotic failure in 1594 patients treated by
transanal total mesorectal excision. Ann Surg 2018;269:700-11.
8. Mege D, Hain E, Lakkis Z, Maggiori L, Prost À la Denise J, et al. Is trans-anal total mesorectal excision really safe and better than
laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-
matched study in 68 patients. Colorectal Dis 2018;20:O143-51.
9. Perdawood SK, Thinggaard BS, Bjoern MX. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term
outcomes with laparoscopic and open surgeries. Surg Endosc 2018;32:2312-21.
10. Atallah SB, DuBose AC, Burke JP, Nassif G, deBeche-Adams T, et al. Uptake of transanal total mesorectal excision in North America:
initial assessment of a structured training program and the experience of delegate surgeons. Dis Colon Rectum 2017;60:1023-31.
11. Koedam TWA, Veltcamp Helbach M, van de Ven PM, Kruyt PM, van Heek NT, et al. Transanal total mesorectal excision for rectal
cancer: evaluation of the learning curve. Tech Coloproctol 2018;22:279-87.
12. Cottin V, Delafosse B, Viale JP. Gas embolism during laparoscopy: a report of seven cases in patients with previous abdominal surgical
history. Surg Endosc 1996;10:166-9.
13. Blaser A, Rosset P. Fatal carbon dioxide embolism as an unreported complication of retroperitoneoscopy. Surg Endosc 1999;13:713-4.
14. Ratcliffe F, Hogan AM, Hompes R. CO2 embolus: an important complication of TaTME surgery. Tech Coloproctol 2017;21:61-2.
15. Dickson EA, Penna M, Cunningham C, Ratcliffe FM, Chantler J, et al. Carbon dioxide embolism associated with total mesorectal
excision surgery. Dis Colon Rectum 2019;62:794-801.
16. van der Pas MHGM, Haglind E, Cuesta MA, Fürst A, Lacy AM, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II):
short-term outcomes of a randomised, phase 3 trial. Lancet 2013;14:210-8.
17. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, et al. Short-term endpoints of conventional versus laparoscopic- assisted surgery
in patients with colorectal cancer ( MRC CLASICC trial ): multicentre , randomised controlled trial. Lancet 2005;365:1718-26.
18. Detering R, Roodbeen SX, van Oostendorp SE, Dekker JT, Sietses C, et al. Three-year nationwide experience with transanal total
mesorectal excision for rectal cancer in the Netherlands: a propensity score-matched comparison with conventional laparoscopic total
mesorectal excision. J Am Coll Surg 2019;228:235-44.
19. Bjoern MX, Nielsen S, Perdawood SK. Quality of life after surgery for rectal cancer: a comparison of functional outcomes after
transanal and laparoscopic approaches. J Gastrointest Surg 2019;23:162-30.